Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.44 |
| ▸ | CTSB | P07858 | 2/20 | 0.44 |
| ▸ | CTSK | P43235 | 2/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TACR1 | P25103 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4023967 | 1.00 | CTSL (0.44) | CTSLCTSBCTSKNAAATSHR | |
| SCHEMBL6184368 | 1.00 | CTSL (0.44) | CTSLCTSBCTSKNAAATSHR | |
| SCHEMBL4021721 | 1.00 | CTSL (0.44) | CTSLCTSBCTSKNAAATSHR | |
| SCHEMBL4021471 | 1.00 | CTSL (0.44) | CTSLCTSBCTSKNAAATSHR | |
| SCHEMBL13720352 | 0.86 | TSHR (0.38) | CTSLCTSBCTSKNAAATSHR | |
| SCHEMBL8112362 | 0.80 | SMN1; SMN2 (0.34) | MAOBOPRM1 | |
| SCHEMBL8112359 | 0.80 | SMN1; SMN2 (0.34) | MAOBOPRM1 | |
| SCHEMBL21107627 | 0.80 | SMN1; SMN2 (0.34) | MAOBOPRM1 | |
| SCHEMBL4024334 | 0.78 | GRM5 (0.37) | CTSLCTSBCTSKTACR1TAAR1 | |
| SCHEMBL4022735 | 0.77 | CTSL (0.42) | CTSLCTSBCTSKNAAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7569579-B2 | for inhibition of HIV replication and treatment of acquired immune deficiency syndrome | SMITHKLINE BEECHAM CORPORATION (US) | 2009-08-04 | — | — | US | disclosed |
| EP-1569934-A2 | CYCLOPROPYL COMPOUNDS AS CCR5 ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-09-07 | — | — | EP | disclosed |
| WO-2004055010-A2 | CYCLOPROPYL COMPOUNDS AS CCR5 ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-07-01 | — | — | WO | disclosed |